Category: TRACE

TraCe Progress: September 2025

Administrative: Molly Van Wyk is no longer TraCe-bMPS admin. Assumed Bonnie’s job as Sr. Admin in BME. Will continue to help until position is replaced. Quality Systems meetings are moving to Wednesdays only: 9:30 -10:00 AM Progress meetings will be

Posted in TRACE

Comparing Apical and Basal Secretome Levels in Static vs. Apical Flow Conditions

We’ve long speculated that adding fluid flow over our tissue models would reduce the concentration of pro-inflammatory factors secreted in response to inflammatory challenges, dampening the overall inflammatory state compared to static culture. We now have evidence that this is

Posted in TRACE

The Feasibility of Using Flow Cytometry to Quantify Cellular Markers in hToC Collagen Gels

Introduction Over the past few months, I have been characterizing and comparing iPSC-derived monocytes (iMonocytes) with peripheral blood-derived (PB) monocytes. As I wrap up these experiments, we’ve decided to look at marker expression on iMonocytes and PB monocytes once they

Posted in TRACE

The Yimei Method for Analyzing PDMS Beam Deflection in the μSiM Vasc-SkM

Image analysis for force from videos of deflected PDMS beams In the summer, Yimei Du from University of Rochester visited Truskey lab to help with the μSiM Vasc-SkM system. Besides working with the chip culture, she helped improve the image

Posted in TRACE

Investigating BCRP Efflux Activity in hCMEC/D3

A central goal of our research is to replicate the blood–brain barrier (BBB) within the µSiM platform. To establish this platform as a valid tool for transport neurotoxicity assays and drug development studies, it is essential to confirm that the

Posted in TRACE Tagged with: ,

Quality System and LOI Updates (August ’25)

LoI and QS Slides for NIH monthly mtg 28 Aug 2025 Letters of Intent Draft sent to C-Path on August 15 CRS/ICANS JDM    

Posted in TRACE

Quality System Update (June ’25)

Status of the Quality System Team – June 27, 2025 Quality System Update – 27 June 2025

Posted in TRACE

A DDT for ICANS Risk Assessment in T Cell–Engaging Bispecific Antibody Immunotherapies: Strategy and Rationale

Work in progress … **************** T cell–Engaging Immunotherapies Pose a Predictable but Complex RiskT cell–engaging bispecific antibodies (BsAbs), particularly those targeting CD3 and a tumor-associated antigen, have emerged as a powerful class of immunotherapies. These agents leverage endogenous T cells

Posted in TRACE

μSiM Vasc-SkM update 2025.06.24

Since the last TraCe-bMPS update in April, we continued to explore different conditions to optimize the μSiM hVasc-SkM systems to obtain stable results.  Enhanced imaging for PDMS beams with Rhodamine staining  Previously we established a MATLAB program that detects the

Posted in TRACE

2025 Rochester MPS Day

The 2025 Rochester MPS Day Summary provides an overview of the event, highlighting registration details, participant feedback, and suggestions for future improvements. The event had a total of 130 registrations, with 88 in-person and 26 virtual attendees. Participants represented various organizations,

Posted in TRACE Tagged with:
0
    0
    Your Cart
    Your cart is emptyReturn to Shop